Design and baseline characteristics of the PerfectFit study: A multicenter cluster-randomized trial of a lifestyle intervention in employees with increased cardiovascular risk by Kouwenhoven-Pasmooij, T.A. (Tessa) et al.
STUDY PROTOCOL Open Access
Design and baseline characteristics of the
PerfectFit study: a multicenter
cluster-randomized trial of a lifestyle
intervention in employees with increased
cardiovascular risk
Tessa A. Kouwenhoven-Pasmooij1,2,3*, Bosiljka Djikanovic2,4,5, Suzan J. W. Robroek2, Pieter Helmhout6,
Alex Burdorf2 and M. G. Myriam Hunink1,7,8
Abstract
Background: The prevalence of unhealthy lifestyles and preventable chronic diseases is high. They lead to disabilities
and sickness absence, which might be reduced if health promotion measures were applied. Therefore, we developed
the PerfectFit health promotion intervention with a “blended care”-approach, which consists of a web-based health risk
assessment (HRA) including tailored and personalized advice, followed by motivational interviewing (MI). We
hypothesize that adding MI to a web-based HRA leads to better health outcomes. The objective is to describe the
design and baseline characteristics of the PerfectFit study, which is being conducted among employees with high
cardiovascular risk in the military workforce, the police organization and an academic hospital.
Methods: PerfectFit is a cluster randomized controlled trial, consisting of two arms. Based on cardiovascular risk
profiling, done between 2012 and 2014, we included employees based on one or more risk factors and motivation to
participate. One arm is the ‘limited’ health program (control) that consists of: (a) an HRA as a decision aid for lifestyle
changes, including tailored and personalized advice, and pros and cons of the options, and (b) a newsletter every
3 months. The other arm is the ‘extensive’ program (intervention), which is additionally offered MI-sessions by trained
occupational physicians, 4 face-to-face and 3 by telephone, and is offered more choices of health promotion activities in
the HRA. During the follow-up period, participants choose the health promotion activities they personally prefer. After
six and twelve months, outcomes will be assessed by online questionnaires. After twelve months the cardiovascular risk
profiling will be repeated. The primary outcome is self-reported general health. Secondary outcomes are self-reported
work ability, CVD-risk score, sickness absence, productivity loss at work, participation in health promotion activities,
changes in lifestyle (smoking, alcohol consumption, physical activity, stress management) and body mass index.
Furthermore, a process evaluation and an economic analysis will be performed.
Discussion: Additional coaching using MI is expected to be a key factor for success of the web-based HRA in
employees with increased cardiovascular risk. This “blended care”-approach may be an essential strategy for effective
health promotion activities.
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Introduction
Background
Although life expectancy has significantly increased over
the past decades in many countries worldwide, the
prevalence of unhealthy lifestyles, preventable chronic
diseases and disabilities is rising [1–3]. Combined with
an ageing workforce, today’s sustainable employability
and well-being of employees are under increasing pres-
sure. Major risk factors for their well-being are adverse
lifestyle habits, such as physical inactivity, unhealthy
diet, smoking, alcohol and stress. These lifestyle behav-
iors are associated with chronic diseases, and among
them, the most common are cardiovascular disease
(CVD) and diabetes. These diseases not only produce
high healthcare costs, but also high indirect costs to so-
ciety due to productivity losses [4–6]. There is a clear
need for health promotion interventions that are effect-
ive and feasible among employees.
Web-based health promotion interventions, such as a
web-based health risk assessment (HRA), have been in-
creasingly used [7–9]. They have the potential of a broad
reach and, if appropriately designed and implemented,
may promote health and well-being, reduce absenteeism,
and increase work productivity [10–12], thus leading to a
positive “return on investment” [13, 14]. A recent meta-
analysis showed, however, that these intervention effects
were found to decline after intervention completion. This
report stated that there is a need for innovative techniques
to help participants maintain their lifestyle changes [15]. A
counselling technique that has shown promising results in
changing and maintaining health behavior is Motivational
Interviewing (MI) [16–23]. MI is a patient-centered coach-
ing technique, and is based on four principles: showing
empathy; addressing discrepancy between current behavior
and an alternative lifestyle behavior; reinforcing the clients’
sense of self-efficacy; and respectfully dealing with the cli-
ents’ resistance to change [24]. Whereas an HRA informs a
participant of their risks of CVD and the options for risk
reduction, MI is used to help the participant evoke and
strengthen intrinsic motivation for lifestyle changes by
respecting individual preferences and autonomy. HRA
complemented with MI could be considered a form of
“blended care”. This type of care involves an internet
approach and face-to-face care blended into one inte-
grated treatment [25]. As of recently, the blended
approach has been increasingly used to effectively influ-
ence changes in lifestyle behaviors [26] [27].
Based on a “blended care” approach, we developed
and implemented an intervention study called PerfectFit.
PerfectFit is aimed at employees who are 40 years or
older, have high physical and mental work demands,
and possess at least one risk factor for cardiovascular
disease [28]. We hypothesized that adding MI to an
HRA improves the effectiveness and sustainability in
changing unhealthy lifestyles and reducing risk factors
for chronic diseases [26]. The objective of this study
was to find out whether adding MI to a web-based
HRA leads to further improvement in the overall
health status and in secondary outcomes such as par-
ticipation in health activities, work ability, sickness
absence and productivity at work, and lifestyle behav-
ior. In this paper, a detailed description of the study
design is presented, along with the baseline character-
istics of participants. Short- and long-term results of
the intervention, as well as a process and an eco-
nomic evaluation will be presented in future papers.
Methods
Study design
The PerfectFit study is a cluster randomized control
trial [29] (cRCT) among employees of three organizations,
aimed to compare two groups: a purely internet-based ap-
proach (limited or control intervention) and a group that
is exposed to the internet-based approach supplemented
with MI (“the blended approach”, extensive intervention).
The internet approach consists of a web-based HRA (later
addressed as “HRA“) with tailored and personalized advice
for health behavior change as well as pros and cons of the
options for change. In the extensive intervention, the
HRA is supplemented with face-to-face care provided by
an (in-house) occupational physician (OP) using MI. The
elements of the intervention are based on existing mod-
ules, previously evaluated RCTs [22, 30–32] and a recent
meta-analysis [33]. Measurements were done at baseline
and will be repeated after 6 and after 12 months.
Participants were included between 2012 and 2014
after providing written informed consent. There were no
risks associated with participating in PerfectFit. Confi-
dentiality was guaranteed during the study for all partici-
pants, as no information about the cardiovascular risk
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profiling, the HRA, or the coaching was provided to
others than stated in the Participant Information Form.
Ethical approval was obtained from the Medical Ethical
Committee of Erasmus MC Rotterdam (METC) by regis-
tration number MEC 2012–459. The trial was registered
on November 14th of 2014 at the Netherlands Trial Regis-
ter by registration number NTR4894.
After trial commencement, three OPs withdrew be-
cause of other priorities in work or due to personal is-
sues, resulting in the loss of one military cluster and less
inclusions than expected. In order to achieve sufficient
power, we obtained approval of the METC to include an
additional organization (i.e., an academic hospital).
Study setting
The study is being performed among employees of three
Dutch organizations: the military force, the police force,
and an academic hospital. All organizations have an
in-company occupational health center. Prior to the
start of PerfectFit, all involved OPs of these health cen-
ters were introduced to the design and the goals of the
PerfectFit study.
Study population
The study population consisted of military personnel of
ten Dutch military bases in different geographical re-
gions in the Netherlands (n = 4207), executive personnel
of three units of the police force in the western, central,
and northern part of the Netherlands (n = 4086), and all
health professionals of six wards (intensive cares and
emergency rooms) of an academic hospital (n = 207).
Based on previous data of 10,624 employees from a
range of companies [34], we estimated 57.3 % (n = 5444)
to be eligible, based on having at least one of three risk
factors (obesity, smoking, lack of physical activity).
An entry point for recruitment of the study population
was cardiovascular risk profiling (later in text: cardio
screening). In the military force, all military employees
of 40 years and over are expected to have this cardio
screening once every three years. In the other two orga-
nizations, this type of screening is voluntary.
Recruitment of participants
Aiming for optimal participation and commitment
among participants and OPs, we obtained endorsement
for this intervention study from both the boards of di-
rectors and the workers’ councils to perform this study.
Recruitment in the military force started in 2012, in the
police force in 2013, and in the hospital in 2014. Follow-
up measurements will be completed by October 2015.
Information on the cardio screening and the Per-
fectFit study was repeatedly given in different formats
(e.g., intranet publications, organizational magazine,
and PerfectFit flyers, that were given out to applicants
to the cardio screening). In the hospital, an additional
information session was organized for the managers of
the participating wards. Employees who were 40 years
or older received the PerfectFit-flyer and a letter of invi-
tation for the cardio screening signed by the highest
manager. Participation in the PerfectFit study was vol-
untary and free of charge. The cardio screening and
coaching sessions could be done during working hours,
in contrast to completing the HRA and undertaking any
individually chosen health activities.
Inclusion criteria for the study
Participants in this study were 40 years and older who
presented with at least one CVD risk factor during the
baseline cardio screening. The age group 40 years and
older was chosen for two reasons. Firstly, cardiovascular
risk scores such as the Framingham Risk Score [35] and
the European SCORE function start at the age of 40.
Secondly, cardio screening is mandatory for military
personnel in this age group [36]. The screening was per-
formed by the OPs of the participating health centres.
The cardio screening consisted of three components:
(1) a short questionnaire with questions related to per-
sonal lifestyle and family history; (2) anthropometric mea-
surements; and (3) blood measurements. In a face-to-face
session, the OP provided “usual care”-advice according to
the applicable Dutch guidelines [37].
The short questionnaire used in the cardio screening
consisted of eight questions on health behavior such as
smoking (yes, no); meeting the Dutch physical activity
norm of exercising five times a week at moderate inten-
sity for at least half an hour (yes, no); family and per-
sonal history of cardiovascular diseases (yes, no), such as
suffering from atrial fibrillation (yes, no); a first degree
family member with angina pectoris or a history of heart
attack (yes, no); and ever being diagnosed with diabetes
(yes, no) or hypertension (yes, no). Participants were also
asked whether they were being treated with prescription
drugs for hypertension or heart problems (yes, no).
For blood pressure, weight, height and serum mea-
surements, the OPs or their assistants used the instru-
ments that are available for their daily practice. These
instruments could vary between OPs, but were the same
throughout the study. Systolic and diastolic blood pres-
sures (in mmHg) were measured twice in a seated position
at rest, and average blood pressure values were used.
Waist circumference was measured halfway between the
lower rib and the iliac crest, as is advised by the Dutch
obesity recommendations for general practitioners [38].
Serum was analysed for total cholesterol, HDL, LDL, tri-
glycerides (mmol/l), and glucose (mmol/l). If the glucose
level exceeded 11.1, then also HbA1c (%) was measured.
These three components of the cardio screening pro-
vided entry points for the study, as it was used to
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identify employees at high risk for CVD. Inclusion cri-
teria were met if a person had at least one of the follow-
ing risk factors for CVD:
1) Angina or myocardial infarction in first degree
relatives;
2) Physical inactivity, i.e. not meeting the guideline of
physical activity at moderate intensity less than 30 min
a day for 5 days per week or comparable effort;
3) Smoking;
4) Self-reported diabetes mellitus or random
glucose ≥ 11.1 mmol/l;
5) Obesity, defined as BMI ≥ 30 kg/m2 and / or waist
circumference ≥ 102 cm for men or BMI ≥ 30 kg/m2
and/or ≥ 88 cm for women.
6) Hypertension (diastolic value > 90 mm Hg or a
systolic value > 140 mmHg) or the use of
antihypertensive drugs;
7) Dyslipidaemia (total cholesterol ≥ 5 mmol/l or LDL
cholesterol ≥ 2.5 mmol/l or triglycerides: ≥ 1.7,mmol/l
or HDL cholesterol: ≤ 1.0 mmol/l).
Employees who met the above mentioned inclusion
criteria were excluded from participation if they had (1)
manifest CVD (history of myocardial infarction, heart
failure, or cerebrovascular accident); (2) a terminal illness;
or (3) a history of psychosis. A flowchart of participants is
shown in Fig. 1.
Study interventions
After the cardio screening at baseline, employees who
were included in both the extensive and the limited
study intervention groups, were invited by the OP to log
on to the web-based HRA, by giving them a personal
voucher-code.
Web-based HRA
The web-based HRA consists of a web-based electronic
questionnaire, including questions on lifestyle, work, family
history, medical history, and motivation to change, which
takes 30 to 45 min to fill out. Based on the answers on
these questions, as well as on the baseline anthropometric
and blood measurements that are integrated in the online
system, the web-based HRA generates tailored and person-
alized advice to the participant, which are presented as
low-risk (green), intermediate-risk (orange), or high-risk
(red) profiles. Personalized advice includes a suggestion of
choice out of health promotion activities, based on the par-
ticipant’s risk profile, preferences and motivational aspects,
according to the transtheoretical model of health behavior
change [39]. These optional choices can be selected from a
list of activities that are “usual care” for each organization.
Prior to the inclusion period, this list was constructed by
the OPs and the research team, and it includes health
promotion activities on lifestyle items (i.e. sports facil-
ities, dietician, psychologist). This web-based HRA can
be considered as a patient decision aid, since it meets
Fig. 1 Flow of clusters and participants until allocation within the trial
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the six qualifying criteria [40]. The flowchart of the
intervention is shown in Fig. 2.
For the participants in both intervention arms, follow-
up questionnaires are conducted after 6 and 12 months,
but without any tailored advice as feedback. In case of
non-response to a questionnaire after two weeks, an
automatic electronic reminder is sent to the employee.
After another two weeks without response, the employee
is contacted by a member of the research team remind-
ing him/her to fill out the questionnaire and/or to pro-
vide assistance if needed.
Limited (control) intervention
The limited health intervention program consists of the
following elements:
a) a web-based HRA (described above), including
tailored and personalized advice for health behavior
change, with a suggestion of choice out of three
“usual care” health promotion activities for every
identified risk factor. This is followed by usual care,
according to Dutch OP guidelines [41].
b) an electronic newsletter of approximately two pages,
sent every three months. The newsletter includes
general information on PerfectFit and on a healthy
lifestyle.
Extensive intervention
In the extensive intervention group, the limited interven-
tion program is extended with personalized MI sessions
with an OP, together with additional tailoring based on
motivational elements in the web-based HRA and an add-
itional motivational paragraph in the newsletters.
MI is conducted in the form of individual coaching
sessions run by trained OPs. Altogether, they include
seven motivational coaching sessions: three face-to-face
sessions (30–45 min per contact) and four telephone
contacts (15–30 min per contact) [42]. The MI training
for OPs was organized as a continuous medical educa-
tion (CME) session and after successful completion of
the training OPs received credits. The training was free
of charge and it consisted of three full days of group
training by a certified MI trainer with 3 follow-up coach-
ing sessions of 4 hours each [43]. During the training,
OPs became familiar with the basic principles of MI and
they practiced techniques needed for conducting MI. The
aim was to elicit long-term healthy behavior in the
participants.
Fig. 2 Flowchart of the interventions, including a web-based Health Risk Assessment (HRA) with tailored advice and suggestions of choices, and
motivational interviewing
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To assure and maintain a high level of quality of MI
during the intervention period, we conducted two quality
assurance activities [44]. First, after every three months,
each OP was asked to audio record the first face-to-face
consultation with a participant, using a voice recorder. Re-
corded sessions were transcribed verbatim and analyzed
using the validated Motivational Interviewing Treatment
Integrity code (MITI) for the presence of core elements of
the MI technique, such as reflexivity, open-questioning,
and empathy [45, 46]. Scorings were done by the first
author and a co-investigator in this study, who are both
experienced MI-coaches and familiar with the scoring
technique. Within a month after the recordings, the OPs
received feedback on the quality of their MI-techniques.
Second, after every MI session with participants, OPs had
to fill out a form related to the MI session with a par-
ticipant, such as if it was a face-to-face or telephone
session, the amount of time it took, and what stage of
change the participant was in (5 stages, ranging from
pre-contemplation to maintenance).
The online advice within the HRA additionally includes
tailoring based on motivational aspects such as intention
to change and personal preferences, and it includes three
more suggestions of choice for health promotion activities.
In contrast to usual care, these additional suggestions of
choice include e-health interventions, fitness centers with
national coverage, and the use of an activity tracker
(accelerometer). The accelerometer is offered for free
and is primarily aimed at providing “biofeedback” to
those participants who are physically inactive and who
are motivated to improve their level of physical activity
by using this small monitoring device during twelve
consecutive weeks [47].
Outcome measures
The following outcome measures will be taken into
account:
Primary outcome measure:
General health
At baseline, 6 months and 12 months, we measure (d)
general health using the first question of the Short Form
36 Health Survey (SF-36) [48] (‘Overall, how would you
rate your health?’), which has five possible answers, ran-
ging from ‘poor’ to ‘excellent’.
Secondary outcome measures:
Quality of life
Quality of life and its utility values will be calculated
using the EuroQol 5 dimensions self-report question-
naire (EQ-5D) [49] and two domains from the SF-36
(physical functioning and vitality) [48]. The EQ-5D is a
health status classification system consisting of five di-
mensions: mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression. We distinguish three
levels for each dimension: no problems, moderate prob-
lems, and extreme problems. Within the SF-36, 4 ques-
tions are asked for physical functioning with 5 answering
options, ranging from “totally agree” to “totally disagree”.
For vitality 4 questions are asked with 6 answering options
ranging from “all the time” to “never”.
CVD-risk score
CVD-risk will be estimated at baseline and after 12 months,
using the European SCORE function (EuroSCORE), the
Framingham Risk Score (FRS), and the QRISK2. The
EuroSCORE [35, 50] estimates the 10-year risk for total
fatal CVD-risk, based on age, sex, smoking, blood pres-
sure, and total cholesterol. The FRS estimates the 10-year
risk for CVD mortality and morbidity by adding hyper-
tension treatment status, HDL-cholesterol, and diabetes
status [36, 51, 52]. The QRISK2 [28] estimates the risk
of CVD by adding ethnicity, diabetes, family history for
angina or heart attack, chronic kidney disease, atrial
fibrillation, blood pressure treatment, rheumatoid arth-
ritis, cholesterol/HDL ratio, and body mass index.
Obesity
Obesity, measured with waist circumference (in cm) and
Body Mass Index (BMI,kg/m2), was determined at base-
line and will be repeated at 12 month follow-up.
Lifestyle
At baseline and after 6 and 12 months, current behavior
is assessed for smoking, physical activity, alcohol con-
sumption, and nutrition, measured as adherence to Dutch
public health guidelines (yes/no), i.e., not smoking [53],
being moderately physically active for 30 min on at least
5 days a week [54], not drinking more than 1 (women) or
2 (men) glasses of alcohol a day [55], eating at least 200 g
of vegetables per day [55], and eating at least 2 pieces of
fruit per day [55] .
At baseline, self-reported intentions to change behav-
ior targeting smoking, physical activity, alcohol, dietary
behavior or body weight will be assessed. For smoking,
intentions to change are measured using dichotomous
response scales (yes/no). For the other lifestyle items,
the answering options are dichotomized into ‘I will start
this month; I will start within 6 months; I will start, but
I don’t know when’ and ‘I would like to, but I don’t have
enough time; I would like to, but I can’t because of a dis-
ease, a disability or a doctor advised me not to; other’.
After 6 months, actual lifestyle behavior change will be
measured by the number and type of health promotion
activities they choose to participate in, within the 6 months
after baseline (participants’ responsiveness to the
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intervention). Also the chosen mode of delivery (pro-
vided by employer or not) will be assessed.
Work ability
Work ability will be measured at baseline, 6 months and
12 months, using the Work Ability Index (WAI) ques-
tionnaire [56], which consists of seven dimensions: an
individual’s (i) physical and (ii) mental demands related
to work, (iii) diagnosed diseases, (iv) experienced work
limitations due to disease, (v) sick leave in the previous
12 months, (vi) work ability prognosis, and (vii) mental
resources. The WAI index is derived as the sum score
of the ratings on each dimension. The range of the
summative index is 7–49, which is categorized into “poor”
(7–27), “moderate” (28–36), “good” (37–43), and “excellent”
(44–49) work ability [57].
Productivity at work
Productivity at work and, if applicable, the reason for
any self-reported loss in productivity was measured at
baseline and will be repeated after 12 months. We use
the Quantity and Quality (QQ) method [58], which is
derived from the PRODISQ [59, 60]. On 10-point nu-
merical scales, participants are asked how much work
they performed during regular hours on their last regu-
lar workday and what the quantity of the work was com-
pared to normal.
We also quantify to what degree employees are
present at work but limited in their job performance due
to any health problems, by using the short version of the
Work Limitations Questionnaire (WLQ-8) [61–63]. The
WLQ-8 consists of four dimensions: physical de-
mands (2 items), time management (2 items), mental-
interpersonal demands (2 items), and output demands
(2 item). Individuals are asked to base their responses
on their previous two weeks of work and to rate im-
pairment on a 5-point scale ranging from “always” to
“never” with an additional response item “does not
apply to my job”.
Process evaluation
After the intervention period, several process characteris-
tics will be evaluated using the RE-AIM model [64, 65],
which consists of the following five elements:
1) Reach (eligibility, number of cardio screenings,
percentages of inclusions and exclusions,
individuals’ characteristics, and compliance and
determinants of the participants to the screening,
HRA, MI-counselling sessions, and 6 and
12 months follow-up measurements);
2) Effectiveness (outcomes at 6 and 12 months);
3) Adoption (characteristics of OPs and clusters);
4) Implementation (amount, duration, timing and
quality of MI-counselling sessions, satisfaction of
participants with the sessions ); and
5) Maintenance (long-term implementation).
Participants’ opinions of the perceived usefulness of
the web-based HRA, of the coaching, and of the impact
on their lifestyle change will be evaluated at six months,
on a 5-points Likert scale (from 1 = strongly disagree to
5 = strongly disagree). Participants’ satisfaction with the
OP will also be measured at six months, using standard
questions based on the PSOHQ [66] .
Sample size and power calculation
The primary outcome measure in this study is general
health. Based on a study of more than 4000 asymptomatic
Dutch individuals [67], we assumed that the average value
for general health score measured by the SF-36 within our
target study population is 71 (SD 19, scale 0–100). Based
on an intervention study that assessed general health,
albeit with a less intensive intervention [68], we assume
a relevant difference in the general health score between
the intervention and control groups after 12 months of
10 % in favor of the intervention group. With a power of
80 %, a significance level of 5 %, two-tailed testing, a com-
pensation for cluster randomization with an estimated
intra-cluster correlation coefficient of 0.05, the assump-
tion of similar groups, and with the intention of demon-
strating superiority, approximately 220 participants per
group are needed to demonstrate a difference in treatment
effect of 10 % between the two groups. With an expected
participation of 50 % (based on previous studies of health
interventions for military personnel) and a loss to follow-
up of 30 %, the RCT required inviting 2 × 634 individuals,
so 1268 in total.
Randomization, blinding, and allocation to interventions
Military bases, regional police forces, and hospital wards
were randomly assigned as ‘clusters’ to one of the two
intervention groups. A total of 18 clusters were random-
ized, which were equally divided in 9 clusters that were
allocated to the limited intervention and 9 clusters that
were allocated to the extensive intervention. In each of
these clusters, one or more OPs were assigned to con-
tribute to PerfectFit, based on shown interest. We chose
for a cluster design to ensure that the OPs were only ac-
tive within a single study arm. The organizational unit
was the preferred cluster for two reasons. First, OPs
from the same organizational unit were all trained to
execute the intervention so that discussions among col-
leagues would not bias the results. Second, grouping par-
ticipants from the same organizational unit into the same
intervention group will prevent so-called “contamination
effects” among participants, i.e., talking and sharing
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experiences about involvement in two different types of
interventions, which might influence their behaviors
[69, 70].
In the military force we constructed ten clusters con-
sisting of military ground force army bases located in
different regions in The Netherlands. Since the police
force was facing a large reorganization with possible re-
placements of OPs from one organizational unit to an-
other, only two clusters could be constructed, based on
organizational units in different regions. Randomization
in the academic hospital was performed at the ward
level, creating a total of 6 clusters.
For all organizations, the OPs only perform work for
the health center within that particular organizational
unit. Clusters were ordered according to their sizes, i.e.
the number of potential eligible participants. For each
pair of clusters of similar size within one organization,
one of the clusters was randomly allocated to the exten-
sive intervention and the other to the limited intervention.
Randomization took place after an OP from the unit had
confirmed participation, and prior to the inclusion of indi-
vidual participants. A researcher who was not otherwise
involved in the trial used version 3.0.1 of The R Foun-
dation for Statistical Computing for the randomization.
Researchers, participating OPs, and participants were not
blinded for the group allocation, since this was impossible
given the nature of the intervention and the cluster design.
Statistical analyses
Demographic and socio-economic characteristics of par-
ticipants such as age, gender, education, profession, and
income level, were collected at the beginning of the study.
For the baseline characteristics of Tables 1 and 2, we used
descriptive statistics to generate number and percentages
for dichotomous and categorical variables, and to generate
means and standard deviations of continuous variables.
To get insight into the differences between groups, Chi-
Square tests and ANOVA-tests were performed.
Future analyses will be performed according to the
Intention-to-treat principle [71]. Repeated measurements
with mixed models techniques will be used to compare
the primary outcome (general health scores) between the
extensive and limited intervention groups, adjusted for
potential confounders such as socioeconomic determi-
nants (including employment status, profession, income
level, education), and taking into account the cluster
randomization (multilevel analysis). A cost analysis will be
performed to determine the costs of the extensive health
intervention compared to the limited health intervention,
including the change in health care consumption.
Economic evaluation
An economic evaluation will be performed, according to
the Dutch guidelines for cost-effectiveness analyses, to
evaluate the trade-off between costs and benefits. Ana-
lyses will be performed both from the perspective of the
organization and from a societal perspective. In this
study we will consider direct and induced costs of the
intervention. The timeframe of the analyses is 12 months
and we will use a model for extrapolation to long-term
results. The cost-benefit analysis performed from the
organizational perspective will include the differences in
employability (in monetary units) and the additional
organizational costs for applying the elements from the
extensive intervention in addition to the limited inter-
vention. A secondary analysis will be performed in
which we will simulate a no-HRA-scenario and calculate
the costs and benefits without either one of our inter-
ventions as reference. In the cost-effectiveness analyses
from a societal perspective, effectiveness will be expressed
using QALY’s, whereas costs will be expressed as total
healthcare costs (direct plus induced costs) and societal
costs. Direct healthcare costs consist of costs of the inter-
vention programs and costs for adapting the intervention
for the target groups (including construction and use of
the web-portal and MI-training of OPs). Induced health-
care costs consist of healthcare consumption (outpatient
visits, diagnostic and therapeutic procedures, medication,
and hospital admissions). Societal costs consist of costs of
employee absence in order to participate in the interven-
tion, absenteeism, productivity at work, individual costs
for undertaking health promotion activities (including
contribution fees to a sports centre and time costs), and
any additional travel costs and parking expenses.
Results
Baseline characteristics of participants
Figure 1 shows the CONSORT diagram [72] of the flow
of clusters and participants through the first phases of
the trial. In total, 9 clusters (n = 217), were assigned to
the limited intervention (control), and 9 clusters (n = 274)
to the extensive intervention (intervention). One cluster
dropped out after randomization and before any cardio
screenings were done, because the only OP within this
cluster had other priorities in work. Three more OPs
dropped out before any cardio screenings were done, two
because of personal problems and one because she left her
job. A total of 652 employees undertook the cardio
screening. Based on these cardio screenings, 91.4 %
(n = 598) were found to have risk factors for CVD, of
whom 82.3 % were included (n = 493). Reasons for no
inclusion were the presence of exclusion criteria or
retirement or having to go abroad for work in the
near future. For 16 participants the baseline question-
naire was missing, but we did receive blood- or
anthropometric-measurements. The number of miss-
ings ranged from n = 1 (for the variable age) to n = 40
(for the variable level of education).
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Baseline characteristics of participants in the three or-
ganizations are presented in Table 1. The military and
police forces included a majority of males, whereas the
hospital included mostly females. Among participants of
the police force more than 76 % had a BMI higher than
25 kg/m2, and in the military force this percentage was
80.5 %. The percentage in the hospital of 46 % is lower
and is similar to the average for the Dutch population.
Table 2 presents the baseline characteristics of the ex-
tensive intervention versus control study groups. The
average age of the participants was 52, and 81.4 % were
male. The randomization was successful in creating study
Table 1 Baseline characteristics of participants included in the PerfectFit-study according to organization ( n = 491)
Organization 1 Organization 2 Organization 3 P value
(Police) (Military) (Hospital)
n = 262 (53 %) n = 170 (35 %) n = 59 (12 %)
Age, mean (sd) 52 (5.8) 49 (4.6) 53 (6.5) <0.000*
Gender:
Male 201 (82.7 %) 163 (98.2 %) 16 (27.6 %) <0.000*
Educational level
Low 39 (16.7 %) 16 (9.9 %) 11 (20 %) <0.000*
Medium 147 (63.1 %) 87 (53.7 %) 22 (40 %)
High 47 (20.2 %) 59 (36.4 %) 22 (40 %)
Hypertensiona 78 (31.2 %) 73 (44.5 %) 22 (39.3 %) 0.021*
Body Mass Index category
<25 kg/m2 62 (24.9 %) 34 (20.1 %) 32 (55.2 %) <0.000*
25-30 kg/m2 141 (56.6 %) 101 (59.8 %) 22 (37.9 %)
>30 kg/m2 46 (18.5 %) 34 (20.1 %) 4 (6.9 %)
Waist circumference, cm :
High (female >88 cm; male >102 cm) 100 (41.3 %) 71 (43.0 %) 30 (52.6 %) 0.299
Obesityb 104 (43.5 %) 75 (45.5 %) 30 (52.6 %) 0.462
Family history of CVDc 97 (37.6) 61 (39.4) 24 (42.9) 0.754
Diabetes mellitus (DM) type IId 10 (4.0) 3 (1.9) 1 (1.8) 0.408
Dyslipidemiae 238 (92.6 %) 154 (91.7 %) 56 (94.9 %) 0.715
Health risk behavior:
Lack of physical activity 107 (42.0) 42 (26.9) 20 (37.0) 0.009*
Smoking 42 (16.5) 27 (16.9) 3 (5.4) 0.088
Framingham 10-year CVD risk score categoryf
Low (<10 %) 153 (66.5 %) 120 (78.9 %) 32 (58.2 %) 0.003*
Intermediate (≥10 %, <20 %) 68 (29.6 %) 22 (14.5 %) 20 (36.4 %)
High (≥20 %) 9 (3.9 %) 10 (6.6 %) 3 (5.5 %)
Number of inclusion criteria:
1 51 (19.8 %) 26 (15.4 %) 7 (11.9 %) 0.235
2 68 (26.5 %) 62 (36.7 %) 21 (35.6 %)
3 77 (30.0 %) 43 (25.4 %) 20 (33.9 %)
≥4 61 (23.7 %) 38 (22.5 %) 11 (18.6 %)
*statistically different, continuous measurements based on ANOVA test and categorical measurements based on Chi-Square test
aHypertension is defined as diastolic blood pressure higher than 90 mmHG or systolic blood pressure higher than 140mmHG or taking antihypertensive drugs
bObesity is defined as BMI >30 kg/m2 or waist circumference >88 cm for females or >102 cm for males
cFamily history of CVD is defined as a first degree family member who suffered a CVD at any age
dDiabetes is defined as having a sober blood glucose higher than 6.1 or self-reported diagnosis of diagnosis
eDyslipidemia is defined as having increased levels of at least one type of lipids in the blood (total cholesterol ≥ 5 mmol/l, or LDL cholesterol ≥ 2.5 mmol/l; or
triglycerides: ≥ 1.7,mmol/l, or HDL cholesterol: ≤ 1.0 mmol/l)
fEuroSCORE and QRISK2 will be calculated after completion of the intervention, at 12 months
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Table 2 Baseline characteristics of the study population (demographics, health and work-related factors) in two intervention arms
Limited Intervention Extensive Intervention P value
n = 218 n = 275
Age, mean (sd) 52.1 (6.0) 50.7 (5.4) <0.006*
Organization 0.007
Police 124 (57.1) 138 (50.4)
Military 60 (27.6) 110 (40.1)
Hospital 33 (15.2) 26 (9.5)
Gender:
Male 154 (77.0 %) 226 (84.6 %) 0.036*
Educational level 0.011*
Low 33 (17.5 %) 33 (12.6 %)
Medium 116 (61.4 %) 140 (53.6 %)
High 40 (21.2 %) 88 (33.7 %)
Hypertensiona 73 (35.1 %) 100 (38.2 %) 0.493
Body Mass Index category
<25 kg/m2 64 (29.9 %) 64 (24.4 %) 0.294
25-30 kg/m2 117 (54.7 %) 147 (56.1 %)
>30 kg/m2 33 (15.4 %) 51 (19.5 %)
Waist circumference, cm :
High (female >88 cm; male >102 cm) 79 (39.7 %) 122 (46.0 %) 0.173
Obesityb 81 (40.7 %) 128 (48.9 %) 0.082
Family history of CVDc 78 (38.0 %) 104 (39.4 %) 0.767
Diabetes mellitus (DM) type IId 8 (3.9 %) 6 (2.3 %) 0.314
Dyslipidemiae 197 (91.6 %) 251 (93.3 %) 0.484
Health risk behavior:
Lack of physical activity 73 (35.6 %) 96 (36.9 %) 0.770
Smoking 23 (11.1 %) 49 (18.6 %) 0.026*
Framingham 10-year CVD risk score categoryf
Low (<10 %) 123 (66.5 %) 182 (72.2 %) 0.430
Intermediate (≥10 %, <20 %) 52 (28.1 %) 58 (23 %)
High (≥20 %) 10 (5.4 %) 12 (4.8 %)
Number of inclusion criteria:
1 43 (20.3 %) 41 (15.0 %) 0.323
2 64 (30.2 %) 87 (31.9 %)
3 63 (29.7 %) 77 (28.2 %)
≥4 42 (19.8 %) 68 (24.9 %)
*statistically different, continuous measurements based on ANOVA test, categorical measurements based on Chi-Square test
aHypertension is defined as diastolic blood pressure higher than 90 mmHG or systolic blood pressure higher than 140mmHG or taking antihypertensive drugs
bObesity is defined as BMI >30 kg/m2 or waist circumference >88 cm for females or >102 cm for males
cFamily history of CVD is defined as a first degree family member who suffered a CVD at any age
dDiabetes is defined as having a sober blood glucose higher than 6.1 or self-reported diagnosis of diagnosis
eDyslipidemia is defined as having increased levels of at least one type of lipids in the blood (total cholesterol ≥ 5 mmol/l, or LDL cholesterol ≥ 2.5 mmol/l; or
triglycerides: ≥ 1.7,mmol/l, or HDL cholesterol: ≤ 1.0 mmol/l)
fEuroSCORE and QRISK2 will be calculated after completion of the intervention, at 12 months
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groups with similar characteristics. Only for smoking a
difference between the groups was found (p = 0.026). The
CVD risk based on the Framingham score showed that
more than 30 % of our study population is at intermediate
or high risk, without differences in distribution between
the two groups (p = 0.430).
Discussion
The PerfectFit study aims to establish whether adding
MI to a web-based HRA is a key-factor for improving ef-
fectiveness in changing unhealthy lifestyles and reducing
risk factors for chronic diseases. MI is known to improve
BMI, total blood cholesterol, systolic blood pressure, and
blood alcohol concentration [73]. By adding MI, this su-
periority RCT combines the advantages of an online per-
sonalized and tailored approach with the advantages of a
face-to-face approach, thus aiming to improve participa-
tion and sustained effectiveness of workplace health pro-
motion programs [74].
Web-based healthcare (eHealth) is receiving growing
attention since it can tailor interventions to target popu-
lation characteristics (e.g., specific risk factors), thereby
facilitating wider access and encouraging self-care, and
possibly reducing health-care costs and improving efficacy
[75]. However, a proven feature of eHealth is that its effect
decreases after the intervention has been completed [15].
Our blended approach of adding MI to a web-based HRA
is promising in several ways. First, we expect an increase
of lifestyle changes, since previous research showed dose–
response relationships between exposure to an intervention
(number and duration of exposures) and behavior change
outcomes [73, 76]. Second, it may lead to a higher sustain-
ability of these lifestyle changes, since there is evidence that
providing face-to-face counselling with a higher number of
overall contacts was associated with greater short and
long-term effectiveness [76]. MI has a large potential to fill
the gap between the intention to change and the actual
behavior change, commonly referred to as the intention-
behavior gap [77]. This potential was previously demon-
strated for lifestyle changes such as physical activity and a
healthy diet [78–80]. MI is a unique tool for evoking and
strengthening intrinsic motivation for a more sustainable
change in lifestyle [13–19].
Our study design is unique for both its blended design
of the intervention using a qualified decision aid and the
follow-up at 6 and 12 months, which enables us to
evaluate not just the initiation of health activities [9] but
also the sustainability of lifestyle changes [81]. A second
strength is the target population of employees in highly
demanding jobs from three types of working organiza-
tions, whose workplace productivity and sickness ab-
sence might benefit from our intervention. Another
strength is that the intervention is implemented within
existing health centers and by their own OPs, improving
external validity and making the results generalizable to
larger companies. For the purpose of this study, a large
investment was done for the OPs to master MI, which
will remain beneficial to the organizations after comple-
tion of the study. Both the OPs from the extensive group
and those from the limited group (after completion of
the study), are educated to use the MI-technique, and
skills they acquire and master during the time of the
study and immediately afterwards can be internalized
and incorporated in their everyday practice with all em-
ployees. From the perspective of the organization and
society, these investments may pay off in the long run:
an economic evaluation will be performed to analyze
whether this truly is the case.
The study has three primary limitations. First, the effects
on lifestyle changes may be affected by the healthy volun-
teer bias, since the study sample consists of employees of
organizations who were actively recruited and who volun-
teered to participate [82]. Although we found differences
in characteristics between organizations (Table 1), the po-
tential bias will effect both the intervention and limited
group alike, and will not have a large effect on our results
(Table 2). Second, an attrition bias may occur at the
follow-up measurements since those who achieve lifestyle
changes might be more willing to do the final assessment
than those who do not [83]. We will try to prevent this by
sending personal invitations for final measurements by
the OPs and having the OPs stimulate the participant to
also fill out the questionnaire. A third issue is that blinding
of the OPs, the participants and the investigators would
have been preferred but could not be done in this real-life
pragmatic trial.
The equal distribution of health factors of our partici-
pants between both the intervention and control groups,
suggests that we will be able to evaluate the intervention-
effects with minimal adjustments. Although there is no
statistical difference in BMI between the groups, the
percentages of participants that are overweight (BMI >
25 kg/m2) exceeds 70 % in both groups, which is high
compared to 47 % within the general population [84].
This is in line with previous research reporting increas-
ingly high percentages of overweight and obesity in the
military force [85] and in police officers [86]. However,
we are cautiously interpreting overweight in population
groups that are doing physically demanding work, since
it is well known that muscular type of body composition
might lead to higher BMI [87]. Therefore, in our study we
also rely on the waist circumference, in order to have an
accurate estimation of obesity.
Dyslipidemia, another risk-factor for CVD, exceeds 90 %
within both study groups, which could be caused by our
strict cut-off value for LDL-cholesterol (>2.5 mmol/l).
Nevertheless, since we found that a majority of our par-
ticipants has more than 1 inclusion criteria and that
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over 30 % has intermediate or high Framingham risk
scores, we can assume that changes in health behaviors
can tackle these health and occupational hazards. Ac-
tual lifestyle changes will be measured and will also be
related to the intention to change at baseline, which
will give us a more accurate picture of the participants’
intention-behavior gap.
To keep the workforce vital and productive, there is a
growing need for effective and affordable health promo-
tion strategies which can also be easily implemented. A
key component of this study is MI, which has several el-
ements that promise to be beneficial for both partici-
pants and healthcare providers. MI is a well-described
and practical approach that respects individual choices
and leads to an increased responsibility for their own
health [24, 40]. By adding counselling sessions using MI
in the intervention group, participants will be involved
in a shared decision making-process related to their
lifestyles. We hypothesize that, once participants discover
their inner strengths and motivations, their health-behavior
gains will be more sustainable and will be maintained over
time [15]. Upcoming papers will assess to what extent this
hypothesis can be confirmed and whether this blended care
approach is an essential strategy for future health promo-
tion programs.
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